Prognostic Value of Some Biochemical Markers in Breast Cancer
NCT05699577 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2023-01-26
Summary
breast cancer is the most common type of cancer in women and first cause of cancer death among them. in Egypt it constitutes 33% of female cancer cases and more than22000 new cases diagnosed each year. there are many prognostic factors for breast cancer as Tumer size, axillary lymph node status, hormonal receptor status, and tumer markers as Ca15-3 and interferon gamma.
Conditions
- Breast Cancer Female
Interventions
- DIAGNOSTIC_TEST
-
serum sample for ELIZA
ELIZA for Ca15-3 and interferon gamma
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-28
- Primary Completion
- 2023-12-31
- Completion
- 2023-12-31
Countries
- Egypt
Study Locations
More Related Trials
-
Aberrant Expression of Micro RNA for Diagnosis of Breast Cancer
NCT04720508 ·Status: UNKNOWN
-
Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer.
NCT07056205 ·Status: ENROLLING_BY_INVITATION
-
One Week Adjuvant Radiotherapy for Breast Cancer
NCT05150535 ·Status: UNKNOWN ·Phase: NA
-
Cardiac Toxicity of Hypo Fractionated Radiotherapy in Left Breast Cancer
NCT05358093 ·Status: UNKNOWN
-
UNFOLD Study Egypt
NCT06188494 ·Status: COMPLETED
-
Prediction in Silico of Pathological Response in a Prospective Cohort Study of Early Breast Cancer Patients
NCT05981326 ·Status: RECRUITING ·Phase: NA
-
Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer
NCT00897416 ·Status: COMPLETED
-
Biomarkers for Breast Cancer Risk in African American Women
NCT01736306 ·Status: COMPLETED
-
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Doxorubicin Among Egyptian Breast Cancer Patients
NCT05733026 ·Status: UNKNOWN
-
Study of Biomarkers in Tissue Samples From Patients With Breast Cancer
NCT01004796 ·Status: UNKNOWN
-
Concordance of the Biology of Primary Breast Carcinoma and the Biology of Recurrence .
NCT07275203 ·Status: NOT_YET_RECRUITING
-
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil
NCT00897091 ·Status: COMPLETED
-
Evaluation of Breast Cancer Screening Program at Assiut Governorate
NCT06403917 ·Status: NOT_YET_RECRUITING
-
Identification of New Prognostic Markers for Breast Cancer.
NCT03436069 ·Status: RECRUITING
-
Abbreviated Breast MRI in Cancer Detection
NCT03870659 ·Status: COMPLETED
-
Biomarkers in Patients With Metastatic Breast Cancer
NCT05871788 ·Status: NOT_YET_RECRUITING
-
Early Detection of Breast Cancer Among Syrian Women
NCT07056686 ·Status: ENROLLING_BY_INVITATION
-
A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer
NCT02761616 ·Status: COMPLETED
-
Circulating microRNA 21 Expression Level Before and After Neoadjuvant Systemic Therapy in Breast Carcinoma
NCT05151224 ·Status: UNKNOWN
-
Towards Early Detection of Breast Cancer in High Risk Population
NCT05268913 ·Status: UNKNOWN
-
Prophylactic Mastectomy: Prospective Evaluation of the Correlation Between Skin Flap Thickness, Residual Glandular Tissue and Skin Necrosis by Imaging and Clinical Examination
NCT05162677 ·Status: RECRUITING
-
S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313
NCT00949013 ·Status: COMPLETED
-
Diagnostic and Prognostic Value of MicroRNA in Breast Cancer Patients
NCT04778202 ·Status: UNKNOWN
-
Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma
NCT06357338 ·Status: ENROLLING_BY_INVITATION
-
Inflammatory Blood Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
NCT05468710 ·Status: UNKNOWN